| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/10/2013 | CN103200962A Recombinant viral vectors and methods for inducing an immune response to yellow fever virus |
| 07/10/2013 | CN103200961A Methods and compositions for immunization against virus |
| 07/10/2013 | CN103200960A Vaccine against ehrlichia canis and associated methods |
| 07/10/2013 | CN103200959A Combined antigen and DNA vaccine for preventing and treating autoimmune diseases |
| 07/10/2013 | CN103200954A Nachra7 agonists and nachra7 antagonists for treating ulcerative colitis (uc) and crohn's disease (cd) |
| 07/10/2013 | CN103200953A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
| 07/10/2013 | CN103200943A Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members |
| 07/10/2013 | CN103200933A Porous degradable polyelectrolyte microspheres as vaccine vector |
| 07/10/2013 | CN103194472A Porcine epizootic diarrhea virus S1 protein fusion gene and recombinant bacillus megaterium, and their use |
| 07/10/2013 | CN103194471A Swine transmissible gastroenteritis virus S/N protein fusion gene and recombinant lactococcus lactis, and their use |
| 07/10/2013 | CN103194470A Swine transmissible gastroenteritis virus antigen fusion gene and recombinant bacillus megaterium, and their use |
| 07/10/2013 | CN103194455A Efficiently-expressed porcine granulocyte macrophage-colony stimulating factor gene and application of expression protein of gene |
| 07/10/2013 | CN103194454A Efficiently-expressed porcine interleukin-2 gene and application of expression protein of porcine interleukin-2 gene |
| 07/10/2013 | CN103194413A Serotype 4 haemophilus parasuis (HPs) vaccine strain |
| 07/10/2013 | CN103194412A Serotype 5 haemophilus parasuis (HPs) vaccine strain |
| 07/10/2013 | CN103193885A Anti-EPHRINB2 antiboies and methods using same |
| 07/10/2013 | CN103193870A Dengue virus degeneration vaccine and application thereof |
| 07/10/2013 | CN103193869A Cattle food-and-mouth disease virus A type synthetic peptide and preparation and application thereof |
| 07/10/2013 | CN103193865A Sendai virus antigen peptide and application thereof in Sendai virus infection detection |
| 07/10/2013 | CN103191444A Method for preparing HPV16L2 recombinant adenovirus vaccine |
| 07/10/2013 | CN103191442A Anti-HIV-1-virus tuberculosis gene vaccine, and preparation method and application thereof |
| 07/10/2013 | CN103191426A New application of rituximab and traditional Chinese medicine |
| 07/10/2013 | CN103191425A Combination medicine containing rituximab and lightyellow sophora root |
| 07/10/2013 | CN103191424A Astragalus polysaccharide nanoliposome capable of improving livestock and poultry immunity and preparation method thereof |
| 07/10/2013 | CN103191423A Novel anti-breast-cancer Her2 vaccine with dendrimer as carrier |
| 07/10/2013 | CN103191422A Triple oral vaccine for cultivating marine fishes as well as preparation method and use method thereof |
| 07/10/2013 | CN103191421A Application of serotype 5 haemophilus parasuis (HPs) vaccine strain |
| 07/10/2013 | CN103191420A Preparation method of periodic wuchereria malayi compound multivalent DNA (deoxyribonucleic acid) vaccine |
| 07/10/2013 | CN103191419A Novel anti-breast-cancer Her2 vaccine with degradable polymer as carrier |
| 07/10/2013 | CN103191157A Propolis flavone liposome for improving livestock and poultry immunity and preparation method thereof |
| 07/10/2013 | CN102516363B CTL (Cytotoxic T Lymphocytes) epitope peptide from PL2L60 source and application thereof |
| 07/10/2013 | CN102335426B Traditional Chinese medicine animal health-care product for foot-and-mouth disease of cattle |
| 07/10/2013 | CN102258776B Combined inactivated vaccine against mycoplasma hyopneumoniae (MHP) and mycoplasma hyorhinis and preparation method thereof |
| 07/10/2013 | CN102247593B Preparation and application of recombinant newcastle disease virus-modified autologous tumor vaccine |
| 07/10/2013 | CN102137929B Anti-CDH3 antibodies labeled with radioisotope label and uses thereof |
| 07/10/2013 | CN102028945B Spirulina polysaccharide immune adjuvant and influenza vaccine containing the same |
| 07/10/2013 | CN101891816B Humanized monoclonal antibody IgG Fab fragment of dermatophagoides farinae 2 allergoid specificity as well as preparation method and application thereof |
| 07/10/2013 | CN101754768B Survivin peptides as cancer vaccines |
| 07/10/2013 | CN101720232B Fc receptor-binding polypeptides with modified effector functions |
| 07/10/2013 | CN101687037B Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates |
| 07/10/2013 | CN101496901B Application of acidic buffer in stable pollen allergen activity |
| 07/10/2013 | CN101448497B Application of composition including nitazoxanide, tizoxanide or its mixture in preparing medicine for hepatitis C |
| 07/10/2013 | CN101415403B Solid oral form of a medicinal preparation and a method for the production thereof |
| 07/10/2013 | CN101094868B Humanized anti-beta7 antagonists and uses therefor |
| 07/10/2013 | CN101052416B Improved adjuvant therapy of G250-expressing tumors |
| 07/09/2013 | USRE44359 Nucleic acid molecules encoding anti-P-selectin antibodies |
| 07/09/2013 | US8481692 Compositions relating to a mutant Clostridium difficile toxin and methods thereof |
| 07/09/2013 | US8481683 Human antibodies that bind CD22 and uses thereof |
| 07/09/2013 | US8481676 Protein and production process and use thereof |
| 07/09/2013 | US8481497 Therapeutic agent for cancer, and method for treatment of cancer |
| 07/09/2013 | US8481333 Detection of degradation products of feline NT-proBNP |
| 07/09/2013 | US8481298 Separation matrix for viral purification |
| 07/09/2013 | US8481064 Method for delivering a therapeutic agent comprising injection of microspheres |
| 07/09/2013 | US8481057 Chlamydial antigens |
| 07/09/2013 | US8481056 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 07/09/2013 | US8481055 Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides |
| 07/09/2013 | US8481054 Pneumococcal serotypes |
| 07/09/2013 | US8481053 Compositions and methods for treating of microbial infections |
| 07/09/2013 | US8481052 Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same |
| 07/09/2013 | US8481051 Cytotoxic T-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof |
| 07/09/2013 | US8481048 Methods for preparing immunogenic conjugates |
| 07/09/2013 | US8481047 Malignant tumor-inhibiting preparation comprising Des A fibrin |
| 07/09/2013 | US8481045 Immunogenic protein constructs |
| 07/09/2013 | US8481043 Nasal immunization |
| 07/09/2013 | US8481042 Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents |
| 07/09/2013 | US8481041 Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy |
| 07/09/2013 | US8481039 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 07/09/2013 | US8481038 Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins |
| 07/09/2013 | US8481037 Recombinant IL-9 antibodies and uses thereof |
| 07/09/2013 | US8481036 Treatment of chronic prostatitis |
| 07/09/2013 | US8481035 Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A |
| 07/09/2013 | US8481034 Anti-VEGFR-3 antibody compositions |
| 07/09/2013 | US8481033 Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (PF4V1) |
| 07/09/2013 | US8481032 Lipocalin-2 antibodies for methods of treatment |
| 07/09/2013 | US8481031 Methods and compositions using Klotho-FGF fusion polypeptides |
| 07/09/2013 | US8481030 Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) |
| 07/09/2013 | US8481029 Human immune therapies using a CD27 agonist alone or in combination with other immune modulators |
| 07/09/2013 | US8481024 Vaccines against tularemia |
| 07/09/2013 | US8481022 Method of treating autoimmune disease with mesenchymal stem cells |
| 07/09/2013 | US8481003 Anti-CD74 immunoconjugates and methods |
| 07/09/2013 | US8481001 Combination therapies comprising quinoxaline inhibitors of P13K-alpha for use in the treatment of cancer |
| 07/09/2013 | CA2575218C Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 07/09/2013 | CA2506538C Bacterial superantigen vaccines |
| 07/09/2013 | CA2494216C Use of dendritic cells (dcs) expressing interleukin 12 (il-12) |
| 07/09/2013 | CA2485992C Mucosal vaccines with chitosan adjuvant and meningococcal antigens |
| 07/09/2013 | CA2445593C Genetically modified yt cell line and use thereof |
| 07/09/2013 | CA2430702C Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/09/2013 | CA2369413C Transmembrane protein expressed in prostate and other cancers |
| 07/09/2013 | CA2354188C Cancer cell vaccine |
| 07/06/2013 | CA2771564A1 Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells |
| 07/04/2013 | WO2013102123A2 Aglycosylated human antibody and fusion protein and uses thereof |
| 07/04/2013 | WO2013102042A2 Dual specific binding proteins directed against il-13 and/or il-17 |
| 07/04/2013 | WO2013101993A2 Dual variable domain immunoglobulins and uses thereof |
| 07/04/2013 | WO2013101964A1 Methods for treatment of breast cancer nonresponsive to trastuzumab |
| 07/04/2013 | WO2013101909A1 Light chain-bridged bispecific antibody |
| 07/04/2013 | WO2013101436A1 Methods of identifying and using mdm2 inhibitors |
| 07/04/2013 | WO2013101195A1 Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (prrs) |
| 07/04/2013 | WO2013100702A1 Immunoglobulin fc variants |
| 07/04/2013 | WO2013098655A2 Antigens and vaccines directed against human enteroviruses |
| 07/04/2013 | WO2013098589A1 Adjuvanted combinations of meningococcal factor h binding proteins |